See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 15, 2006

Pancreatic Cancer McCune-Albright Syndrome Cervical Dysplasia or Human Papilloma Virus (HPV)

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Pancreatic Cancer

This clinical study will compare the effectiveness of an investigational product versus capecitabine in people with advanced or metastatic pancreatic cancer who have failed first line gemcitabine therapy. Volunteers 18 or older may be included who have confirmed pancreatic cancer, have not had recent surgery, have failed first line gemcitabine therapy, and have not had any previous therapy with an EGFR inhibitor, MEK inhibitor, or capecitabine.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat35.html.

-----

McCune-Albright Syndrome

This clinical trial will evaluate how the drug fulvestrant affects girls with progressive precocious puberty associated with McCune Albright Syndrome (MAS). Girls younger than 11 with a diagnosis of progressive precocious puberty before the age of eight who have not received prior treatment for the condition with fulvestrant may be eligible.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat260.html.

-----

Cervical Dysplasia or Human Papilloma Virus (HPV)

Have you recently had an abnormal pap test or been told that you have cervical HPV (human papillomavirus)? If so, you may qualify for an investigational study to evaluate an investigational gel applied intravaginally. The study lasts approximately 27 months and involves up to 16 clinic visits. Women 18-40 who are willing to be on an acceptable method of birth control, are of child-bearing potential, and have had a pap test finding of low-grade squamous intraepithelial lesions (LSIL) or atypical squamous cells of undetermined significance (ASC-US) may qualify.

The research sites are located across the United States and Canada.

More information

Please see http://www.centerwatch.com/patient/studies/cat395.html or http://www.centerwatch.com/patient/studies/cat421.html.

-----

Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.